CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
37 hedge funds and large institutions have $34.6M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.4M | |
| 2 | +$130K | |
| 3 | +$125K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$94K |
| 5 |
CC
Cannell Capital
Alta,
Wyoming
|
+$41.2K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$1.01M | |
| 3 | -$381K | |
| 4 |
Renaissance Technologies
New York
|
-$210K |
| 5 |
D.E. Shaw & Co
New York
|
-$175K |